The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade

BACKGROUND: Sugammadex is a novel neuromuscular reversal agent, but its associated hypersensitivity reaction and high cost have been obstacles to its widespread use. In the interest of reducing the necessary dosage of sugammadex, the reversal time of the combined use of sugammadex and neostigmine fr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Korean J Anesthesiol
Hlavní autoři: Cheong, Soon Ho, Ki, Seunghee, Lee, Jiyong, Lee, Jeong Han, Kim, Myoung-Hun, Hur, Dongki, Cho, Kwangrae, Lim, Se Hun, Lee, Kun Moo, Kim, Young-Jae, Lee, Wonjin
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Society of Anesthesiologists 2015
Témata:
Clinical Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4667139/
https://ncbi.nlm.nih.gov/pubmed/26634077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4097/kjae.2015.68.6.547
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky